Cloning of replication-incompetent herpes simplex viruses as bacterial artificial chromosomes to facilitate development of vectors for gene delivery into differentiated neurons

Human Gene Therapy

Volumn 17, Issue 1, 2006, Pages 93-104

  Schmeisser, Falko ^a   Weir, Jerry P ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DOXYCYCLINE; HERPESVIRUS VECTOR; RETINOIC ACID; TETRACYCLINE;

ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; EMBRYO; GENE CASSETTE; GENE EXPRESSION; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; MOLECULAR CLONING; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; TOXICITY; UL41 GENE; UL48 GENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

BETA-GALACTOSIDASE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELLS, CULTURED; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; GENE EXPRESSION; GENE ORDER; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOPRECIPITATION; LAC OPERON; NEURONS; PEPTIDES; SIMPLEXVIRUS; SUPEROXIDE DISMUTASE; VIRUS REPLICATION;

ANIMALIA; BACTERIA (MICROORGANISMS); HERPESVIRIDAE; PROKARYOTA; SIMPLEXVIRUS;

EID: 30744471194     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.93     Document Type: Article

References (41)

1. ACE, C.I., MCKEE, T.A., RYAN, J.M., CAMERON, J.M., and PRESTON, C.M. (1989). Construction and characterization of a herpes simplex virus type 1 mutant unable to transactivate immediate-early gene expression. J. Virol. 63, 2260-2269.
2. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (2003). Current Protocols in Molecular Biology. (John Wiley & Sons, New York).
3. BORST, E.-M., HAHN, G., KOSZINOWSKI, U.H., and MESSERLE, M. (1999). Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: A new approach for construction of HCMV mutants. J. Virol. 73, 8320-8329.
4. BRUIJN, L.I., MILLER, T.M., and CLEVELAND, D.W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723-749.
5. BRUNE, W., MESSERLE, M., and KOSZINOWSKI, U.H. (2000). Forward with BACs. Trends Genet. 16, 254-259.
6. BURTON, E.A., FINK, D.J., and GLORIOSO, J.C. (2002). Gene delivery using herpes simplex virus vectors. DNA Cell Biol. 21, 915-936.
7. CLEMENT, A.M., NGUYEN, M.D., ROBERTS, E.A., GARCIA, M.L., BOILLEE, S., RULE, M., McMAHON, A.P., DOUCETTE, W., SIWEK, D., FERRANTE, R.J., BROWN, R.H., Jr., JULIEN, J.P., GOLDSTEIN, L.S., and CLEVELAND, D.W. (2003). Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113-117.
8. CUNNINGHAM, C., and DAVISON, A.J. (1993). A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197, 116-124.
9. DELECLUSE, H.-J., HILSENDEGEN, T., PICH, D., ZEIDLER, R., and HAMMERSCHMIDT, W. (1998). Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U.S.A. 95, 8245-8250.
10. DELUCA, N.A., and SCHAFFER, P.A. (1987). Activities of herpes simplex type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15, 4491-4511.
11. DELUCA, N.A., MCCARTHY, A.M., and SCHAFFER. P.A. (1985). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56, 558-570.
12. DENNISTON, K.J., MADDEN, M.J., ENQUIST, L.W., and VANDE WOUDE, G. (1981). Characterization of coliphage λ hybrids carrying DNA fragments from herpes simplex virus type 1 defective interfering particles. Gene 15, 365-378.
13. GAGE, P.J., SAUER, B., LEVINE, M., and GLORIOSO, J.C. (1992). A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J. Virol. 66, 5509-5515.
14. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551.
15. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MULLER, G., HlLLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
16. HORSBURGH, B.C., HUBINETTE, M.M., QIANG, D., MACDONALD, M.L.E., and TUFARO, F. (1999a). Allele replacement: An application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther. 6, 922-930.
17. HORSBURGH, B.C., HUBINETTE, M.M., and TUFARO, F. (1999b). Genetic manipulation of herpes simplex virus using bacterial artificial chromosomes. Methods Enzymol. 306, 337-352.
18. JULIEN, J.-P. (2001). Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded. Cell 104, 581-591.
19. KRISKY, D.M., MARCONI, P.C., OLIGINO, T., ROUSE, R.J., FINK, D.J., and GLORIOSO, J.C. (1997). Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 4, 1120-1125.
20. LACHMANN, R. (2004). Herpes simplex virus-based vectors. Int. J. Exp. Pathol. 85, 177-190.
21. MANSUY, I.M., and BUJARD, H. (2000). Tetracycline-regulated gene expression in the brain. Curr. Opin. Neurobiol. 10, 593-596.
22. MCFARLANE, M., DAKSIS, J.I., and PRESTON, C.M. (1992). Hexamethylene bisacetamide stimulates herpes simplex virus immediate-early gene expression in the absence of trans-induction by Vmw65. J. Gen. Virol. 73, 285-292.
23. MESSERLE, M., CRNKOVIC, I., HAMMERSCHMIDT, W., ZIEGLER, H., and KOSZINOWSKI, U.H. (1997). Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U.S.A. 94, 14759-14763.
24. PRESTON, C.M., MABBS, R., and NICHOLL, M.J. (1997). Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression. Virology 229, 228-239.
25. READ, G.S., and FRENKEL, N. (1983). Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides. J. Virol. 46, 498-512.
26. RIXON, F.J., and MCLAUCHLAN, J. (1990). Insertion of DNA sequences at a unique restriction enzyme site engineered for vector purposes into the genome of herpes simplex virus type 1. J. Gen. Virol. 71, 2931-2939.
27. ROIZMAN, B., and JENKINS, F.J. (1985). Genetic engineering of novel genomes of large DNA viruses. Science 229, 1208-1214.
28. ROSSI, F.M.V., and BLAU, H.M. (1998). Recent advances in inducible gene expression systems. Curr. Opin. Biotechnol. 9, 451-456.
29. SAMANIEGO, L.A., WU, N., and DELUCA, N.A. (1997). The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71, 4614-4625.
30. SAMANIEGO, L.A., NEIDERHISER, L., and DELUCA, N.A. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72, 3307-3320.
31. SCHMEISSER, F., DONOHUE, M., and WEIR, J.P. (2002). Tetracycline- regulated gene expression in replication-incompetent herpes simplex virus vectors. Hum. Gene Ther. 13, 2113-2124.
32. SHIZUYA, H., BIRREN, B., KIM, U.-J., MANCINO, V., SLEPAK, T., TACHIRI, Y., and SIMON, M. (1992). Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. U.S.A. 89, 8794-8797.
33. SMILEY, J.R. (2004). Herpes simplex virus virion host shutoff protein: Immune evasion mediated by a viral RNase? J. Virol. 78, 1063-1068.
34. SMITH, G.A., and ENQUIST, L.W. (1999). Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 73, 6405-6414.
35. URLINGER, S., BARON, U., THELLMANN, M., HASAN, M.T., BUJARD, H., and HILLEN, W. (2000). Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. U.S.A. 97, 7963-7968.
36. WAGNER, M., RUZSICS, Z., and KOSZINOWSKI, U.H. (2002). Herpesvirus genetics has come of age. Trends Microbiol. 10, 318-324.
37. WEIR, J.P. (2001). Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors. J. Neurovirol. 7, 43-51.
38. WEIR, J.P., and DACQUEL, E.J. (1995). Plasmid insertion vectors that facilitate construction of herpes simplex virus gene delivery vectors. Gene 154, 123-128.
39. WEIR, J.P., STEFFY, K.R., and SETHNA, M. (1990). An insertion vector for the analysis of gene expression during herpes simplex virus infection. Gene 89, 271-274.
40. WU, N., WATKINS, S.C., SCHAFFER, P.A., and DELUCA, N. (1996). Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70, 6358-6369.
41. YU, D., SMITH, G.A., ENQUIST, L.W., and SHENK, T. (2002). Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76, 2316-2328.